What are GLP-1 receptor agonists?
GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally releases after eating. It signals satiety to the brain, slows gastric emptying, and modulates insulin release. GLP-1 receptor agonists are medications that activate those same receptors, producing a more sustained version of what your body already does naturally after a meal.
Two GLP-1 receptor agonists have become the dominant options for clinician-supervised weight management:
- Semaglutide — a weekly injectable that activates GLP-1 receptors, studied extensively in the STEP trial program and available as branded Wegovy (weight management) or Ozempic (blood sugar management), as well as through compounding.
- Tirzepatide — a dual GLP-1 and GIP receptor agonist, studied in the SURMOUNT program, available as branded Zepbound (weight management) or Mounjaro (blood sugar management), and through compounding.
Both require a prescription. Neither is available legally without a clinician evaluation.
Who qualifies for a GLP-1 prescription?
Clinical eligibility for a GLP-1 prescription for weight management generally follows criteria similar to those used in the major clinical trials:
- BMI of 30 or higher — the standard threshold for obesity as a standalone indication.
- BMI of 27 or higher with a weight-related health condition — conditions such as hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, or cardiovascular disease can lower the BMI threshold for clinical appropriateness.
- No contraindications — a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) is a contraindication for semaglutide and tirzepatide. A clinician screens for this and other relevant history during the intake process.
- Commitment to protocol adherence — GLP-1 therapy works alongside dietary and lifestyle change. Clinicians look for patients prepared to engage with the full plan.
A legitimate GLP-1 prescription has two non-negotiables: a real clinician making a real prescribing decision, and a licensed US pharmacy filling it.
Branded GLP-1 versus compounded GLP-1
When your clinician issues a GLP-1 prescription, it can be filled in two ways depending on your situation:
Branded GLP-1 through a retail pharmacy
Branded medications like Wegovy, Ozempic, Zepbound, and Mounjaro are FDA-approved finished drug products dispensed through retail pharmacies. They require a valid prescription and may require prior authorization from your insurance plan. Out-of-pocket cost without coverage can be considerable — several hundred to over a thousand dollars per month depending on the medication and dose.
Compounded GLP-1 through a licensed 503A pharmacy
Compounded versions of semaglutide and tirzepatide are prepared by licensed 503A compounding pharmacies under a patient-specific prescription. Compounded medications are not FDA-approved as finished drug products — that distinction matters, and any legitimate provider will be transparent about it. However, they are legally dispensed when a licensed clinician writes the prescription and a licensed 503A pharmacy fills it.
Compounded GLP-1 medications are typically more accessible in terms of cost, and they are not subject to the same supply constraints that have periodically limited availability of branded versions. PepScribe works exclusively with licensed 503A pharmacies — compounded in the USA, no hidden overseas supply chain.
How does the telehealth GLP-1 prescription process work?
Telehealth has made it possible to complete the full clinical evaluation and prescription process without an in-person visit. Here is how it works through a legitimate platform:
- Complete a medical intake. Answer questions about your health history, current medications, weight management goals, and any relevant conditions. This is the clinical documentation basis for the prescribing decision.
- Clinician review. A licensed clinician — physician, NP, or PA — reviews your intake and makes the prescribing determination. Most platforms complete this within 24–48 hours.
- Prescription issued and sent to pharmacy. If you qualify, the clinician sends your prescription directly to a licensed compounding pharmacy. The prescription specifies the GLP-1 agent, dose, and titration schedule appropriate for you.
- Medication shipped to you. The pharmacy prepares and ships your medication, typically arriving within a few business days.
- Ongoing check-ins. A legitimate GLP-1 program includes clinician follow-up to review your response, manage side effects, and adjust dosing as needed over the titration period.
What makes a GLP-1 source legitimate?
The surge in demand for GLP-1 medications has produced a large gray market. Websites offering semaglutide or tirzepatide without a prescription — or through a cursory online quiz that produces an “instant prescription” — are not operating legitimately. Red flags include:
- No required consultation with an actual licensed clinician
- Instant approval without a real intake review
- No licensed 503A pharmacy named in the supply chain (or no disclosure at all)
- Medications shipped from outside the United States
- Prices dramatically below what licensed US pharmacies charge
A legitimate GLP-1 prescription path has a real clinician making a real prescribing decision and a licensed US pharmacy filling the prescription. Those two elements are non-negotiable for safe, legal access.
Frequently asked questions
What do I need to get a GLP-1 prescription?
You need a clinical evaluation by a licensed clinician — physician, NP, or PA — who reviews your health history, weight-management goals, and any contraindications. Most GLP-1 weight-management prescriptions require a BMI of 30+, or 27+ with a weight-related health condition.
Can telehealth prescribe GLP-1 medications?
Yes. Licensed telehealth clinicians can evaluate your eligibility and issue a valid GLP-1 prescription, which is then filled by a licensed pharmacy. No in-person visit is required for the initial evaluation at most telehealth platforms.
How long does it take to get a GLP-1 prescription through telehealth?
Most telehealth platforms complete the clinical review within 24–48 hours of a completed intake. Pharmacy processing and shipping adds a few additional business days.
Is a GLP-1 prescription covered by insurance?
Coverage depends on the specific GLP-1 medication, your insurance plan, and the diagnosis. Prior authorization is common for branded GLP-1s. Compounded GLP-1 options are generally not covered by insurance but are often more affordable out of pocket.
What is the difference between branded and compounded GLP-1?
Branded GLP-1 medications (like Ozempic, Wegovy, Zepbound) are FDA-approved finished drug products dispensed through retail pharmacies. Compounded GLP-1s — semaglutide and tirzepatide — are prepared by licensed 503A compounding pharmacies under a patient-specific prescription. Compounded versions are not FDA-approved as finished drug products, but can be legally prescribed and dispensed through licensed 503A pharmacies.
Who cannot get a GLP-1 prescription?
A personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) are contraindications for most GLP-1 receptor agonists. Active pancreatitis, severe gastrointestinal disease, and certain other conditions may also disqualify someone. A clinician determines this during the intake review.